Quality control of cell-based high-throughput drug screening

The pharmaceutical industry is presently suffering difficult times due to low productivity of new molecular entities. As a major source of drug leads, high-throughput screening (HTS) has been often criticized for its ‘dead end’ lead compounds. However, the fruitful achievements resulting from HTS te...

Full description

Bibliographic Details
Main Authors: Zhiyun Zhang, Ni Guan, Ting Li, Dale E. Mais, Mingwei Wang
Format: Article
Language:English
Published: Elsevier 2012-10-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383512000548